Okuda K, Wolff L, Oliver R, Osborn J, Stoltenberg J, Bereuter J, Anderson L, Foster P, Hardie N, Aeppli D
Department of Periodontology, Niigata University, School of Dentistry, Japan.
J Periodontol. 1992 Feb;63(2):73-9. doi: 10.1902/jop.1992.63.2.73.
The purpose of this study was to determine the microbiological efficacy of an adjunctive minocycline periodontal formulation delivered subgingivally. Subjects were systemically healthy but exhibited severe periodontitis; i.e., probing depths greater than 6 mm. The two study groups included individuals who received minocycline or a placebo periodontal formulation after root planing. Subgingival plaque samples were obtained at baseline; prior to treatment; and at 1, 3, and 6 months. Plaque was evaluated by darkfield microscopy and further analyzed for total dark-pigmented Bacteroides species, P. intermedia, P. gingivalis and Streptococcus, Actinomyces, Eikenella, Actinobacillus, Capnocytophaga, and Fusobacterium species using cultivable flora techniques. In addition, plaque was evaluated for yeast on a selective agar medium. When compared to the placebo, the minocycline group had significantly lower proportions of spirochetes at 1 and 3 months and lower proportions of motile rods at 3 months. Furthermore, when compared to the placebo group, the minocycline patients had lower mean proportions of dark-pigmented Bacteroides spp. and P. intermedia at 1 and 3 months as well as lower proportions of E. corrodens at 1 month. The minocycline group had significant decreases in proportions of spirochetes at 1 and 3 months, motile rods at 1 and 3 months, and increases in cocci at 1, 3, and 6 months when compared to baseline. In the placebo group, root planing was also effective at decreasing spirochetes at 1, 3, and 6 months, but with significant differences seen only at 3 and 6 months. However, the degree of reduction in spirochete proportions was greater in the minocycline group when compared with the placebo group.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定龈下给予的辅助性米诺环素牙周制剂的微生物学疗效。受试者全身健康,但患有重度牙周炎,即探诊深度大于6mm。两个研究组包括在根面平整后接受米诺环素或安慰剂牙周制剂的个体。在基线、治疗前、治疗后1个月、3个月和6个月采集龈下菌斑样本。通过暗视野显微镜对菌斑进行评估,并使用可培养菌群技术进一步分析总深色色素拟杆菌属、中间普氏菌、牙龈卟啉单胞菌以及链球菌、放线菌、艾肯菌属、放线杆菌属、二氧化碳嗜纤维菌属和梭杆菌属。此外,在选择性琼脂培养基上评估菌斑中的酵母菌。与安慰剂相比,米诺环素组在1个月和3个月时螺旋体比例显著降低,在3个月时活动杆菌比例降低。此外,与安慰剂组相比,米诺环素治疗的患者在1个月和3个月时深色色素拟杆菌属和中间普氏菌的平均比例较低,在1个月时腐蚀艾肯菌的比例较低。与基线相比,米诺环素组在1个月和3个月时螺旋体比例显著降低,在1个月和3个月时活动杆菌比例降低,在1个月、3个月和6个月时球菌比例增加。在安慰剂组中,根面平整在1个月、3个月和6个月时也能有效减少螺旋体,但仅在3个月和6个月时出现显著差异。然而,与安慰剂组相比,米诺环素组螺旋体比例的降低程度更大。(摘要截断于250字)